Zobrazeno 1 - 10
of 25
pro vyhledávání: '"J F, Seymour"'
Autor:
W. Townsend, W. Hiddemann, C. Buske, G. Cartron, D. Cunningham, M. J. Dyer, J. Gribben, E. Phillips, M. Dreyling, J. F. Seymour, A. Grigg, T.-Y. Lin, X.-N. Hong, D. Kingbiel, T. G. Nielsen, A. Knapp, M. Herold, R. Marcus
Publikováno v:
HemaSphere, Vol 6, Pp 107-108 (2022)
Externí odkaz:
https://doaj.org/article/2737ee3eca244f0482bfdcecfde6cda0
Autor:
S. Stilgenbauer, E. Tausch, A. W. Roberts, M. S. Davids, B. Eichhorst, M. Hallek, P. Hillmen, C. Schneider, S. Böttcher, R. Popovic, M. T. Ghanim, M. Moran, W. J. Sinai, X. Wang, N. Mukherjee, B. Chyla, W. G. Wierda, J. F. Seymour
Publikováno v:
HemaSphere, Vol 6, Pp 47-48 (2022)
Externí odkaz:
https://doaj.org/article/7176cf0f3fb2482e8cc0556a6086b189
Autor:
L. J. Croner, J. N. Allan, N. Jain, J. F. Seymour, K. Eckert, L. W. K. Cheung, E. Szafer-Glusman
Publikováno v:
HemaSphere, Vol 6, Pp 568-569 (2022)
Externí odkaz:
https://doaj.org/article/a6400fdc3b0d4f7ca1e3f201d76ded68
Autor:
A, Lasocki, J F, Seymour
Publikováno v:
Clinical Radiology. 77:328-336
Central nervous system (CNS) involvement by haematological malignancies is uncommon, and generally associated with a poor prognosis. Neuroimaging plays a key role in the accurate diagnosis, including in the critical differentiation from other process
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::904fb552bf973d9c65c05f74fe9b111e
https://doi.org/10.1016/j.crad.2022.01.043
https://doi.org/10.1016/j.crad.2022.01.043
Publikováno v:
Internal medicine journal. 42(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e68ff79e7d3f1235fb7d2f00a943a1aa
https://pubmed.ncbi.nlm.nih.gov/22805693
https://pubmed.ncbi.nlm.nih.gov/22805693
Autor:
S, Lingaratnam, M A, Slavin, L, Mileshkin, B, Solomon, K, Burbury, J F, Seymour, R, Sharma, B, Koczwara, S W, Kirsa, I D, Davis, M, Prince, J, Szer, C, Underhill, O, Morrissey, K A, Thursky
Publikováno v:
Internal medicine journal. 41(1b)
An abundance of new evidence regarding treatment strategies for neutropenic fever is likely to contribute to variability in practice across institutions and clinicians alike.To describe current clinical practices in Australia, by surveying haematolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::576d48df205aee895df42f5de0dae650
https://pubmed.ncbi.nlm.nih.gov/21272175
https://pubmed.ncbi.nlm.nih.gov/21272175
Autor:
S, Lingaratnam, M A, Slavin, B, Koczwara, J F, Seymour, J, Szer, C, Underhill, M, Prince, L, Mileshkin, M, O'Reilly, S W, Kirsa, C A, Bennett, I D, Davis, O, Morrissey, K A, Thursky
Publikováno v:
Internal medicine journal. 41(1b)
The current consensus guidelines were developed to standardize the clinical approach to the management of neutropenic fever in adult cancer patients throughout Australian treating centres. The three areas of clinical practice covered by the guideline
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::715edacf020a1ce5a4379d6e32155823
https://pubmed.ncbi.nlm.nih.gov/21272171
https://pubmed.ncbi.nlm.nih.gov/21272171
Autor:
M A, Slavin, J, Szer, A P, Grigg, A W, Roberts, J F, Seymour, J, Sasadeusz, K, Thursky, S C, Chen, C O, Morrissey, C H, Heath, T, Sorrell
Publikováno v:
Internal medicine journal. 34(4)
Treatment of invasive fungal infections is increasingly complex. Amphotericin B deoxycholate has long been the mainstay of treatment. However, there has been increasing recognition of both the propensity for nephro-toxicity in haematology, transplant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3fd58548eddb02a9fa660cf362e52681
https://pubmed.ncbi.nlm.nih.gov/15892774
https://pubmed.ncbi.nlm.nih.gov/15892774
Publikováno v:
European journal of haematology. 72(1)
The extent of disease in patients with multiple myeloma or related conditions may be difficult to assess. In previous small studies, both FDG-PET (PET) and Tc-99m sestamibi scans (MIBI) have identified sites of occult disease in myeloma.We reviewed t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e46fea00e6452ff8f5f1cc34b1502651
https://pubmed.ncbi.nlm.nih.gov/14962260
https://pubmed.ncbi.nlm.nih.gov/14962260
Autor:
G A, Kennedy, J F, Seymour, M, Wolf, H, Januszewicz, J, Davison, C, McCormack, G, Ryan, H M, Prince
Publikováno v:
European journal of haematology. 71(4)
Alemtuzumab (anti-CD52, Campath-1H) has recently been shown to be effective in the treatment of a range of hematological malignancies, including B-cell chronic lymphocytic leukemia and T-cell prolymphocytic leukemia. We undertook a phase II study to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5a43ba802987ae61801fa644a4b76c89
https://pubmed.ncbi.nlm.nih.gov/12950233
https://pubmed.ncbi.nlm.nih.gov/12950233